维普中文期刊产品整合服务
49篇 您的检索式:作者名="Gaedcke"
    题名 作者 年代 出处 被引量
1MicroRNA in rectal cancer显示文摘In rectal cancer,one of the most common cancers worldwide,the proper staging of the disease determines the subsequent therapy.For those with locally advancedrectal cancer,a neoadjuvant chemoradiotherapy(CRT) is recommended before any surgery.However,response to CRT ranges from complete response(responders) to complete resistance(non-responders).To date we are not able to separate in advance the first group from the second,due to the absence of a valid biomarker.Therefore all patients receive the same therapy regardless of whether they reap benefits.On the other hand almost all patients receive a surgical resection after the CRT,although a watch-and-wait procedure or an endoscopic resection might be sufficient for those who responded well to the CRT.Being highly conserved regulators of gene expression,micro RNAs(mi RNAs) seem to be promising candidates for biomarkers.Many studies have been analyzing the mi RNAs expressed in rectal cancer tissue to determine a specific mi RNA profile for the ailment.Unfortunately,there is only a small overlap of identified mi RNAs between different studies,posing the question as to whether different methods or differences in tissue storage may contribute to that fact or if the results simply are not reproducible,due to unknown factors with undetected influences on mi RNA expression.Other studies sought to find mi RNAs which correlate to clinical parameters(tumor grade,nodal stage,metastasis,survival) and therapy response.Although several mi RNAs seem to have an impact on the response to CRT or might predict nodal stage,there is still only little overlap between different studies.We here aimed to summarize the current literature on rectal cancer and mi RNA expression with respect to the different relevant clinical parameters.azadeh azizian jens gruber b michael ghadimi jochen gaedcke 2016World Journal of Gastrointestinal Oncology2016,8,5:3
2STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo显示文摘Melanie Spitzner Birte Roesler Christian Bielfeld Georg Emons Jochen Gaedcke Hendrik A. Wolff Margret Rave‐Fr?nk Frank Kramer Tim Beissbarth Julia Kitz Jürgen Wienands B. Michael Ghadimi Reinhard Ebner Thomas Ried Marian Grade 2014Int J Cancer2014,,4:2
3Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g显示文摘Junius Salendo Melanie Spitzner Frank Kramer Xin Zhang Peter Jo Hendrik A. Wolff Julia Kitz Silke Kaulfu? Tim Bei?barth Matthias Dobbelstein Michael Ghadimi Marian Grade Jochen Gaedcke 2013Radiotherapy and Oncology2013,,:2
4Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g<!-- MicroRNA chemoradiosensitivity signature -->显示文摘Junius Salendo Melanie Spitzner Frank Kramer Xin Zhang Peter Jo Hendrik A. Wolff Julia Kitz Silke Kaulfu? Tim Bei?barth Matthias Dobbelstein Michael Ghadimi Marian Grade Jochen Gaedcke 2013Radiotherapy and Oncology2013,,:2
5Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer显示文摘Geng Zhang Peijun He Hanson Tan Anuradha Budhu Jochen Gaedcke B. Michael Ghadimi Thomas Ried Harris G. Yfantis Dong H. Lee Anirban Maitra Nader Hanna H. Richard Alexander S. Perwez Hussain 2013Clinical Cancer Research2013,,18:1
6The mesopancreas is the primary site for R1 resection in pancreatic head cancer: rele- vance for clinical trials显示文摘Gaedcke J Gunawan B Grade M 2010Langenbecks Arch Surg2010,395,4:1
7The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials显示文摘Gaedcke J Gunawan B Grade M 2010Langenbecks Arch Surg2010,395,4:1
8The rectal cancer microR- NAome-microRNA expression in rectal cancer and matched normal mucosa显示文摘Gaedcke J Grade M Carnps J 2012Clin Cancer Res2012,18,18:1
9Investigation of the pharmaceutical and pharmacological equivalence of different hawthorn extracts 显示文摘VERLING W BRAND N GAEDCKE F 2003Phytomedicine2003,10,1:1
10Investigation of the phar- maceutical and pharmacological equivalence of different hawthorn extracts 显示文摘Vierling W Brand N Gaedcke F 2003Phytomedicine2003,,10:1
11The rectal cancer microRNAome-microRNA expression in rectal cancer and matched normal mucosa显示文摘Gaedcke J Grade M Camps J 2012Clin Cancer Res2012,18,18:1
12The mesopancreas is the primary site for R1 resection in pancreatic head eancer :relevance for clinical trials显示文摘Gaedcke J Gunawan B Grade M 2010Langenbecks Arch Surg2010,395,4:1
13The rectal cancer microRNAome-microRNA expression in rectal cancer and matched normal mucosa显示文摘Gaedcke J Grade M Camps J 2012Clin Cancer Res2012,18,18:1
14The mesopancreas is the primary site for Rl resection in pancreatic head cancer: relevance for clinical trials显示文摘Gaedcke r Gunawan B Grade M 2010Langenbecks Arch Surg2010,395,4:1
15Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis显示文摘KaulfuβS Burfeind P Gaedcke J 2009Molecular Cancer Therapeutics2009,8,4:1
16The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies 显示文摘Grade M Wolff HA Gaedcke J 2012Langenbecks Arch Surg2012,397,:1
17Dual silencing of insulin-like growth factor-Ⅰ receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis显示文摘Kaulfuss S Burfeind P Gaedcke J 2009Mol Cancer Ther2009,8,4:1
18The mesopancreas is the primary site for R1 resection in pancreatic head cancer: rel- evance for clinical trials显示文摘Gaedcke J Gunawan B Grade M 2010Langenbecks Arch Surg2010,395,:1
19K-ras and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy显示文摘Gaedcke J GradeM Jung K 2010Radiother Oncol2010,94,1:1
20Rectal cancer: current status of multimodal therapy--when and how显示文摘Gaedcke J Liersch T Hess C 2011Zentralbl Chir2011,136,4:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费